chitosan has been researched along with Diabetic Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, ZL; Lai, CS; Sudirman, S; Yan, YL; Yeh, HI | 1 |
| Abdel-Moneim, A; Abdul-Hamid, M; Galaly, SR; Mohamed, HM; Mostafa, F | 1 |
2 other study(ies) available for chitosan and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Curcumin; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diabetic Nephropathies; Disease Models, Animal; Heart; Kidney; Male; Mice; Mice, Inbred C57BL; Streptozocin | 2019 |
Polydatin and polydatin-loaded chitosan nanoparticles attenuate diabetic cardiomyopathy in rats.
Topics: Animals; Antioxidants; Chitosan; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucosides; Glycated Hemoglobin; Immunohistochemistry; Male; Nanoparticles; Oxidative Stress; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Stilbenes | 2021 |